SCHEMBL628169

SCHEMBL628169

CCCCCCCCCCCCCCCCCC[NH+](C)CCCCCCCCCCCCCCCCCC.FC(F)(F)c1cc([B-](c2cc(C(F)(F)F)cc(C(F)(F)F)c2)(c2cc(C(F)(F)F)cc(C(F)(F)F)c2)c2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc(C(F)(F)F)c1

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GABRA2 P47869 3/20 0.36
GABRB2 P47870 3/20 0.36
DNM1 Q05193 1/20 0.34
CYP3A4 P08684 2/20 0.33
MAPK1 P28482 2/20 0.33
MAPT P10636 1/20 0.33
DPP4 P27487 1/20 0.31
CTSS P25774 1/20 0.31
CTSK P43235 1/20 0.31
TACR1 P25103 1/20 0.31
TSHR P16473 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
PSEN1 P49768 1/20 0.30
PSEN2 P49810 1/20 0.30
APH1B Q8WW43 1/20 0.30
NCSTN Q92542 1/20 0.30
APH1A Q96BI3 1/20 0.30
PSENEN Q9NZ42 1/20 0.30
ICMT O60725 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22689569 0.92 GABRA2 (0.32) GABRA2GABRB2TACR1TSHRPSEN1
SCHEMBL134606 0.82 CYP3A4 (0.35) GABRA2GABRB2CYP3A4MAPK1MAPT
SCHEMBL31749536 0.81 SLC22A1 (0.43) GABRA2GABRB2DNM1CYP3A4MAPK1
SCHEMBL16669245 0.81 SLC22A1 (0.43) GABRA2GABRB2DNM1CYP3A4MAPK1
SCHEMBL6288802 0.79 CYP3A4 (0.34) GABRA2GABRB2CYP3A4MAPK1MAPT
Tetrapentylammonium SCHEMBL527645 0.79 SLC22A1 (0.41) GABRA2GABRB2DNM1CYP3A4MAPK1
Tetrabuthylammonium SCHEMBL16668627 0.79 SLC22A1 (0.41) GABRA2GABRB2DNM1CYP3A4MAPK1
SCHEMBL217662 0.78 CYP3A4 (0.34) GABRA2GABRB2CYP3A4MAPK1MAPT
SCHEMBL15538611 0.78 GABRA2 (0.36) GABRA2GABRB2DNM1CYP3A4MAPK1
Trimethylammonium SCHEMBL219375 0.77 CES2 (0.38) MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 163 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4043500-B1 ETHYLENE·ALPHA-OLEFIN·NON-CONJUGATED POLYENE COPOLYMER, USE THEREOF, AND MANUFACTURING METHOD THEREOF MITSUI CHEMICALS INC (JP) 2025-08-13 EP disclosed
CN-116134090-B Thermoplastic resin composition 株式会社LG化学 2025-05-06 CN disclosed
CN-116209719-B Thermoplastic resin composition 株式会社LG化学 2025-03-28 CN disclosed
EP-3124505-B1 ETHYLENE/ALPHA-OLEFIN COPOLYMER AND LUBRICATING OIL MITSUI CHEMICALS INC (JP) 2025-03-19 EP disclosed
US-12221529-B2 Ethylene copolymer composition and use thereof MITSUI CHEMICALS, INC. (JP) 2025-02-11 US disclosed
CN-114728991-B Ligand compound, transition metal compound, and catalyst composition comprising same 株式会社LG化学 2024-12-20 CN disclosed
CN-118871529-A Thermoplastic resin composition 三井化学株式会社 2024-10-29 CN disclosed
WO-2024204149-A1 ADHESIVE COMPOSITION AND METHOD FOR PRODUCING SAME, AND ADHESIVE SHEET 三井化学株式会社 2024-10-03 WO disclosed
CN-118742629-A Lubricating oil composition 三井化学株式会社 2024-10-01 CN disclosed
EP-4417648-A1 ETHYLENE COPOLYMER COMPOSITION AND USE THEREOF Mitsui Chemicals, Inc. (JP) 2024-08-21 EP disclosed
US-20070100056-A1 Process for producing thermoplastic resin composition MITSUI CHEMICALS, INC. (JP) 2007-05-03 US disclosed
US-20070080483-A1 Process for producing injection molded product MITSUI CHEMICALS, INC. (JP) 2007-04-12 US disclosed
US-20070082998-A1 Process for producing injection molded product MITSUI CHEMICALS, INC. (JP) 2007-04-12 US disclosed
EP-1731533-A1 PROCESS FOR PRODUCING OLEFIN POLYMER Mitsui Chemicals, Inc. (JP) 2006-12-13 EP disclosed
US-20060270812-A1 Copolymerizing ethylene is solution at 120-300 degrees C., with a diarylmethylene- or diarylsilylene-bridged metallocene catalyst and an organoaluminum compound, an alumoxane, or a compound which reacts with the bridged metallocene to form an ion pair; narrow molecular weight distribution. MITSUI CHEMICALS, INC. (JP) 2006-11-30 US disclosed
US-20060116303-A1 decene-ethylene copolymer, zirconium, titanium or hafnium fluorene-containing complexes, organometallics; improved high thermal oxidation stability, viscosity index, low-temperature viscosity properties and shear stability MITSUI CHEMICALS, INC. (JP) 2006-06-01 US disclosed
EP-1661921-A1 Synthetic lubricating oil and lubricating oil composition thereof Mitsui Chemicals, Inc. (JP) 2006-05-31 EP disclosed
EP-1640385-A2 Process for preparing low molecular weight olefin (co)polymer and polymerizing catalyst used therefor MITSUI CHEMICALS, INC. (JP) 2006-03-29 EP disclosed
US-20050131171-A1 Process for preparing low molecular weight olefin (CO) polymer and polymerization catalyst used therefor MITSUI CHEMICALS, INC. (JP) 2005-06-16 US disclosed
EP-1416000-A1 Process for preparing low molecular weight olefin (co)polymer and polymerizing catalyst used therefor Mitsui Chemicals, Inc. (JP) 2004-05-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050131171-A1 Process for preparing low molecular weight olefin (CO) polymer and polymerization catalyst used therefor CYP4F11, WEE2, FAR1 GABRA2 1088/4885GABRB2 1003/4885DNM1 1191/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.